The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours (Q31004882)

28 June 2017

1 reference

title

The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours (English)

1 reference

28 June 2017

Garcea G

1

1 reference

28 June 2017

Lloyd TD

2

1 reference

28 June 2017

Aylott C

3

1 reference

28 June 2017

Maddern G

4

1 reference

28 June 2017

Berry DP

5

1 reference

28 June 2017

1 October 2003

1 reference

European Journal of Cancer

28 June 2017

1 reference

28 June 2017

39

1 reference

28 June 2017

15

1 reference

28 June 2017

2150-2164

1 reference

Rising incidence of hepatocellular carcinoma in the United States

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Increase in primary liver cancer in the UK, 1979-94

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Risk factors for the rising rates of primary liver cancer in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Physiologic considerations in major hepatic resections

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Nonresectional therapies for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Phase II trial of high dose recombinant gamma-interferon in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Molecular therapies for colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous treatment of hepatic neoplasms: A review of current techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Ethanol injection for the treatment of hepatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Intratumor ethanol injection therapy for solitary minute hepatocellular carcinoma. A study of 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection. A trial with a comparison group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Local treatment of colorectal liver metastases: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Liver metastases: results of percutaneous ethanol injection in 14 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

An appraisal of percutaneous treatment of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

1 reference

7 January 2021

Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Fatal liver necrosis following percutaneous ethanol injection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Fatal thrombosis of the portal vein following single-session percutaneous ethanol injection therapy of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous hot saline injection therapy: effectiveness in large hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Laparoscopic ablation of liver adenoma by radiofrequency electrocauthery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Intraoperative radiofrequency ablation using a 3D navigation tool for treatment of colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous Radiofrequency Ablation of Hepatic Tumors During Temporary Venous Occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatic radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Radiofrequency ablation of liver tumors: influence of technique and tumor size

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

[Percutaneous radiofrequency ablation of liver malignancies: first experience with a 200-W radiofrequency generator]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Ultrasound monitoring of temperature change during radiofrequency ablation: preliminary in-vivo results.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Clinical short-term results of radiofrequency ablation in liver cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Activation, aggregation and adhesion of platelets exposed to high-intensity focused ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Localized Tissue Destruction by High-Intensity Focused Ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

High-Intensity Focused Ultrasound in the Treatment of Experimental Liver Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Interstitial laser-induced thermotherapy: influence of carbonization on lesion size

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Selecting source locations in multifiber interstitial laser photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Interstitial laser hyperthermia: a new approach to local destruction of tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Magnetic resonance imaging--guided abdominal interventional radiology: laser-induced thermotherapy of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: technique and prospective results

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous MRI-guided laser-induced thermotherapy for hepatic metastases for colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Treatment of recurrent colorectal liver metastases by interstitial laser photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Interstitial laser treatment of malignant tumours: initial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Biliary structures lead to tumour recurrences after laser-induced interstitial thermotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatic interstitial laser photocoagulation: demonstration and possible clinical importance of intravascular gas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Laparoscopic microwave coagulo-necrotic therapy for hepatocellular carcinoma: a feasible study of an alternative option for poor-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Complications and management of microwave coagulation therapy for primary and metastatic liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Sequential percutaneous microwave coagulation therapy for liver tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Experimental study of large-volume microwave ablation in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Microwave coagulation therapy with interruption of hepatic blood in- or outflow: an experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Laparoscopic microwave coagulation therapy for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Microwave coagulation therapy for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Value of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in relation to tumor size and location

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Percutaneous transhepatic microwave coagulation therapy for hepatocellular carcinoma proliferating in the bile duct

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Liver abscess formation after microwave coagulation therapy applied for hepatic metastases from surgically excised bile duct cancer: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Portal vein thrombosis caused by microwave coagulation therapy for hepatocellular carcinoma: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

A new procedure of percutaneous microwave coagulation therapy under artificial hydrothorax for patients with liver tumors in the hepatic dome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Microwave coagulation therapy accelerates growth of cancer in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Electrolysis and Surgery in Experimental Tumours in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Effects of Varying Potential and Electrolytic Dosage in Direct Current Treatment of Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

A new treatment for unresectable liver tumours: long-term studies of electrolytic lesions in the pig liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Experimental study of electrolysis-induced hepatic necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Liver electrolysis: pH can reliably monitor the extent of hepatic ablation in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Electrolytic Ablation of Colorectal Liver Metastases: 1-Year Histological Patient Follow-Up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Electrolytic ablation as an adjunct to liver resection: Safety and efficacy in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Use of electrolysis as an adjunct to liver resection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

1 reference

7 January 2021

Preliminary experience with percutaneous cryotherapy of liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Laparoscopic cryoablation of hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Cryotherapeutic ablation of liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Repeat hepatic cryotherapy for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Cryotherapy for liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Treatment of colorectal liver metastases by cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Multiple bilobar liver metastases: cryotherapy for residual lesions after liver resection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

[Cryotherapy for primary and secondary liver tumours].

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Cryotherapy for primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Cryotherapy of metastatic carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

[Cryotherapy of liver metastases. Initial results]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Cryotherapy of the resection edge after liver resection for colorectal cancer metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Hepatic cryosurgery in treating colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Cryotherapy for neuroendocrine liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Laparoscopic cryoablation of hepatic metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Anaesthetic experience with laparoscopic cryotherapy. A new technique for treating liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Fluorodeoxyuridine causes bilomas after hepatic cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

World survey on the complications of hepatic and prostate cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

Renal impairment in hepatic cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900553-7

7 January 2021

10.1016/S0959-8049(03)00553-7

Identifiers

DOI

1 reference

28 June 2017

1 reference